Newcastle disease virus: Current status and our understanding

Abstract Newcastle disease (ND) is one of the highly pathogenic viral diseases of avian species. ND is economically significant because of the huge mortality and morbidity associated with it. The disease is endemic in many third world countries where agriculture serves as the primary source of national income. Newcastle disease virus (NDV) belongs to the family Paramyxoviridae and is well characterized member among the avian paramyxovirus serotypes. In recent years, NDV has lured the virologists not only because of its pathogenic potential, but also for its oncolytic activity and its use as a vaccine vector for both humans and animals. The NDV based recombinant vaccine offers a pertinent choice for the construction of live attenuated vaccine due to its modular nature of transcription, minimum recombination frequency, and lack of DNA phase during replication. Our current understanding about the NDV biology is expanding rapidly because of the availability of modern molecular biology tools and high-throughput complete genome sequencing.

[1]  D. Swayne.  laboratory manual for the isolation and identification of avian pathogens , 1998 .

[2]  C. Cantín,et al.  Newcastle disease virus may enter cells by caveolae-mediated endocytosis. , 2007, The Journal of general virology.

[3]  H. E. Alkiston,et al.  NEWCASTLE DISEASE IN VICTORIA , 1942 .

[4]  J. Gorman,et al.  Characterization of the sites of proteolytic activation of Newcastle disease virus membrane glycoprotein precursors. , 1988, The Journal of biological chemistry.

[5]  K. Conzelmann,et al.  Matrix Protein of Rabies Virus Is Responsible for the Assembly and Budding of Bullet-Shaped Particles and Interacts with the Transmembrane Spike Glycoprotein G , 1999, Journal of Virology.

[6]  S. Hotte,et al.  Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. , 2003, Current opinion in molecular therapeutics.

[7]  Identification of a new newcastle disease virus isolate from Indonesia represents an ancestral lineage of class II genotype XIII , 2013, Virus Genes.

[8]  P. Collins,et al.  Role of C 596 in the C-terminal extension of the haemagglutinin – neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus , 2014 .

[9]  Liji Xie,et al.  Complete Genome Sequence Analysis of a Newcastle Disease Virus Isolated from a Wild Egret , 2012, Journal of Virology.

[10]  E. Kaleta,et al.  Newcastle Disease in Free-Living and Pet Birds , 1988 .

[11]  P. Rottier,et al.  The Viral Replication Complex Is Associated with the Virulence of Newcastle Disease Virus , 2010, Journal of Virology.

[12]  W. Cassel,et al.  Newcastle disease virus as an antineoplastic agent , 1965, Cancer.

[13]  E. Stanbridge,et al.  The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling. , 2013, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[14]  P. V. Ravindra,et al.  Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de-novo protein synthesis and caspase activation. , 2008, Virus research.

[15]  Nahum Sonenberg,et al.  Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus , 2000, Nature Medicine.

[16]  A. García-Sastre,et al.  Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses , 2013, PloS one.

[17]  R. M. Iorio,et al.  A Mutation in the Stalk of the Newcastle Disease Virus Hemagglutinin-Neuraminidase (HN) Protein Prevents Triggering of the F Protein despite Allowing Efficient HN-F Complex Formation , 2013, Journal of Virology.

[18]  H. Westbury.  Newcastle disease virus: An evolving pathogen? , 2001, Avian pathology : journal of the W.V.P.A.

[19]  T. Morrison,et al.  Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells , 1997, Journal of virology.

[20]  H. Klenk,et al.  Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. , 1976, Virology.

[21]  S. Elankumaran,et al.  Newcastle Disease Virus Exerts Oncolysis by both Intrinsic and Extrinsic Caspase-Dependent Pathways of Cell Death , 2006, Journal of Virology.

[22]  D. Montefiori,et al.  Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector , 2013, PloS one.

[23]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[24]  D. Diel,et al.  Newcastle disease virus fusion and haemagglutinin-neuraminidase proteins contribute to its macrophage host range , 2013, The Journal of general virology.

[25]  T. Morrison,et al.  Mutational Analysis of Heptad Repeats in the Membrane-Proximal Region of Newcastle Disease Virus HN Protein , 1999, Journal of Virology.

[26]  A. García-Sastre,et al.  Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Schmid,et al.  Engineered newcastle disease virus as an improved oncolytic agent against hepatocellular carcinoma. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  R. Heckert,et al.  Newcastle Disease and Related Avian Paramyxoviruses , 2008 .

[29]  S. Elankumaran,et al.  Recombinant Newcastle disease virus as a vaccine vector. , 2003, Poultry science.

[30]  A. Arnold,et al.  Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy , 2007, Gene Therapy.

[31]  L. Roux,et al.  The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA , 1993, Journal of virology.

[32]  M. Eshaghi,et al.  Identification of phosphoprotein:phosphoprotein and phosphoprotein:nucleocapsid protein interaction domains of the Newcastle disease virus , 2005, Archives of Virology.

[33]  P. Collins,et al.  Role of C596 in the C-terminal extension of the haemagglutinin-neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus. , 2014, The Journal of general virology.

[34]  S. Elankumaran,et al.  The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties. , 2010, Virus research.

[35]  M. Peeples,et al.  Mutation in the matrix protein of Newcastle disease virus can result in decreased fusion glycoprotein incorporation into particles and decreased infectivity , 1984, Journal of virology.

[36]  J. Waldenström,et al.  Prevalence of avian paramyxovirus type 1 in Mallards during autumn migration in the western Baltic Sea region , 2013, Virology Journal.

[37]  P. Collins,et al.  Coordinate Deletion of N-Glycans from the Heptad Repeats of the Fusion F Protein of Newcastle Disease Virus Yields a Hyperfusogenic Virus with Increased Replication, Virulence, and Immunogenicity , 2011, Journal of Virology.

[38]  H. Hirte,et al.  An Optimized Clinical Regimen for the Oncolytic Virus PV701 , 2007, Clinical Cancer Research.

[39]  R. M. Iorio,et al.  Paramyxoviruses: different receptors - different mechanisms of fusion. , 2008, Trends in microbiology.

[40]  Michael B. Fernando,et al.  Newcastle disease virus selectively kills human tumor cells. , 1992, The Journal of surgical research.

[41]  P. Collins,et al.  Evaluation of the Newcastle Disease Virus F and HN Proteins in Protective Immunity by Using a Recombinant Avian Paramyxovirus Type 3 Vector in Chickens , 2011, Journal of Virology.

[42]  M. Peeples,et al.  The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. , 1993, Virology.

[43]  P. Gregersen,et al.  A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire , 1998, Molecular medicine.

[44]  A. Omar,et al.  Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240 , 2013, Oncology reports.

[45]  B. Murphy,et al.  Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys , 2009, Journal of Virology.

[46]  R. Ray,et al.  Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses , 1992, Journal of virology.

[47]  P. T. Emmerson,et al.  Assembly of recombinant Newcastle disease virus nucleocapsid protein into nucleocapsid-like structures is inhibited by the phosphoprotein. , 1997, The Journal of general virology.

[48]  A. García-Sastre,et al.  Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. , 2007, Cancer research.

[49]  D. Swayne,et al.  Avian influenza and Newcastle disease. , 2003, Journal of the American Veterinary Medical Association.

[50]  Hualan Chen,et al.  Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza Viruses , 2006, Journal of Virology.

[51]  V. Schirrmacher,et al.  Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects. , 2001, International journal of oncology.

[52]  B. Peeters,et al.  Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. , 1999, The Journal of general virology.

[53]  A. Gould,et al.  Sequence variation in the Newcastle disease virus genome. , 2006, Virus research.

[54]  E. Villar,et al.  Entry of Newcastle Disease Virus into the host cell: Role of acidic pH and endocytosis , 2013, Biochimica et Biophysica Acta (BBA) - Biomembranes.

[55]  G. Parks,et al.  Incorporation of Host Complement Regulatory Proteins into Newcastle Disease Virus Enhances Complement Evasion , 2012, Journal of Virology.

[56]  K. Pedersen,et al.  Characterization of Newcastle Disease Viruses Isolated from Cormorant and Gull Species in the United States in 2010 , 2012, Avian diseases.

[57]  T. Mettenleiter,et al.  Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus. , 2008, Vaccine.

[58]  P. Collins,et al.  Newcastle Disease Virus Expressing Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Induces Strong Mucosal and Serum Antibody Responses in Guinea Pigs , 2011, Journal of Virology.

[59]  M. Peeples,et al.  Requirements for the Assembly and Release of Newcastle Disease Virus-Like Particles , 2006, Journal of Virology.

[60]  R. M. Iorio,et al.  Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. , 1995, Virology.

[61]  B. Murphy,et al.  Nonsegmented Negative-Strand Viruses as Vaccine Vectors , 2006, Journal of Virology.

[62]  P. Collins,et al.  Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1 , 2010, Vaccine.

[63]  L-Q Wang,et al.  Combination of targeting gene-viro therapy with recombinant Fowl-pox viruses with HN and VP3 genes on mouse osteosarcoma. , 2013, European review for medical and pharmacological sciences.

[64]  Brijesh Singh Yadav,et al.  Isolation of Newcastle disease virus from a non-avian host (sheep) and its implications , 2012, Archives of Virology.

[65]  M. St. Claire,et al.  Recombinant Newcastle Disease Virus Expressing a Foreign Viral Antigen Is Attenuated and Highly Immunogenic in Primates , 2005, Journal of Virology.

[66]  Vanessa R. Melanson,et al.  Amino Acid Substitutions in the F-Specific Domain in the Stalk of the Newcastle Disease Virus HN Protein Modulate Fusion and Interfere with Its Interaction with the F Protein , 2004, Journal of Virology.

[67]  S. Elankumaran,et al.  Prostate-Specific Antigen-Retargeted Recombinant Newcastle Disease Virus for Prostate Cancer Virotherapy , 2013, Journal of Virology.

[68]  P. Rottier,et al.  Virulence of newcastle disease virus: what is known so far? , 2011, Veterinary research.

[69]  T. Mettenleiter,et al.  Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. , 2003, The Journal of general virology.

[70]  HN gene C-terminal extension of Newcastle disease virus is not the determinant of the enteric tropism , 2013, Virus Genes.

[71]  T. Morrison.  Structure and function of a paramyxovirus fusion protein. , 2003, Biochimica et biophysica acta.

[72]  L. McGinnes,et al.  The role of the individual cysteine residues in the formation of the mature, antigenic HN protein of Newcastle disease virus. , 1994, Virology.

[73]  T. Doyle.  A hitherto unrecorded disease of fowls due to a filter-passing virus. , 1927 .

[74]  G. Koch,et al.  Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals. , 2001, Vaccine.

[75]  S. Elankumaran.  Genetically engineered Newcastle disease virus for prostate cancer: a magic bullet or a misfit , 2013, Expert review of anticancer therapy.

[76]  S. Samal,et al.  A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity. , 2011, The Journal of general virology.

[77]  A. García-Sastre,et al.  Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[78]  B. Seal,et al.  Molecular evolution of the Newcastle disease virus matrix protein gene and phylogenetic relationships among the paramyxoviridae. , 2000, Virus research.

[79]  J. Gomori,et al.  Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[80]  S. Moyer,et al.  The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. , 1996, Virology.

[81]  S. D. Boer,et al.  Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. , 2010, Vaccine.

[82]  J. Sheehan,et al.  Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. , 1989, Virus research.

[83]  P. V. Ravindra,et al.  Newcastle disease virus as an oncolytic agent. , 2009, The Indian journal of medical research.

[84]  T. Yoshida,et al.  Correlation of proteolytic cleavage of F protein precursors in paramyxoviruses with expression of the fur, PACE4 and PC6 genes in mammalian cells. , 1994, The Journal of general virology.

[85]  A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functions. , 1992, Virology.

[86]  S. Krishnamurthy,et al.  Newcastle Disease Virus V Protein Is Associated with Viral Pathogenesis and Functions as an Alpha Interferon Antagonist , 2003, Journal of Virology.

[87]  U. Chulan,et al.  Vaccination against newcastle disease , 1982, Tropical Animal Health and Production.

[88]  S. Krishnamurthy,et al.  Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. , 2000, Virology.

[89]  E. Mundt,et al.  Generation of recombinant lentogenic Newcastle disease virus from cDNA. , 1999, The Journal of general virology.

[90]  S. Elankumaran,et al.  Type I Interferon-Sensitive Recombinant Newcastle Disease Virus for Oncolytic Virotherapy , 2010, Journal of Virology.

[91]  A. Israël,et al.  Two factors, IRF1 and KBF1/NF-kappa B, cooperate during induction of MHC class I gene expression by interferon alpha beta or Newcastle disease virus. , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[92]  Y. Huang,et al.  Genomic sequence of an isolate of Newcastle disease virus isolated from an outbreak in geese: a novel six nucleotide insertion in the non-coding region of the nucleoprotein gene , 2004, Archives of Virology.

[93]  T. Mebatsion,et al.  Newcastle Disease Virus (NDV) Marker Vaccine: an Immunodominant Epitope on the Nucleoprotein Gene of NDV Can Be Deleted or Replaced by a Foreign Epitope , 2002, Journal of Virology.

[94]  A. García-Sastre,et al.  Optimization of Human Immunodeficiency Virus Gag Expression by Newcastle Disease Virus Vectors for the Induction of Potent Immune Responses , 2008, Journal of Virology.

[95]  R. Compans,et al.  Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins. , 1999, The Journal of general virology.

[96]  E. Rosenbluth,et al.  Newcastle disease virus in little owls (Athene noctua) and African penguins (Spheniscus demersus) in an Israeli zoo. , 2014, Transboundary and emerging diseases.

[97]  B. Tey,et al.  Newcastle disease virus nucleocapsid protein: self-assembly and length-determination domains. , 2003, Journal of General Virology.

[98]  A. Vaheri,et al.  Molecular Epidemiology of Outbreak-Associated and Wild-Waterfowl-Derived Newcastle Disease Virus Strains in Finland, Including a Novel Class I Genotype , 2012, Journal of Clinical Microbiology.

[99]  A. García-Sastre,et al.  Induction of Cellular Immune Responses to Simian Immunodeficiency Virus Gag by Two Recombinant Negative-Strand RNA Virus Vectors , 2004, Journal of Virology.

[100]  A. Omar,et al.  Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy , 2011, Journal of biomedicine & biotechnology.

[101]  E. Somogyi,et al.  Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implications. , 2006, Virus research.

[102]  J. Willuda,et al.  Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes , 2008, Gene Therapy.

[103]  P. Rottier,et al.  A Single Immunization with Soluble Recombinant Trimeric Hemagglutinin Protects Chickens against Highly Pathogenic Avian Influenza Virus H5N1 , 2010, PloS one.

[104]  M. Hamaguchi,et al.  Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. , 1987, Virology.

[105]  S. Krishnamurthy,et al.  Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence. , 1998, The Journal of general virology.

[106]  L. McGinnes,et al.  The fusion promotion activity of the NDV HN protein does not correlate with neuraminidase activity. , 1993, Virology.

[107]  N. Millar,et al.  RNA editing in Newcastle disease virus. , 1993, The Journal of general virology.

[108]  M. Peeples,et al.  Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy. , 1994, Cancer research.

[109]  T. Yang,et al.  Genomic characterisation of a lentogenic Newcastle disease virus strain HX01 isolated from sick pigs in China , 2012, Virus Genes.

[110]  K. Yusoff,et al.  NDV-induced apoptosis in absence of Bax; evidence of involvement of apoptotic proteins upstream of mitochondria , 2012, Virology Journal.

[111]  B. Peeters,et al.  Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase protein. , 2005, The Journal of general virology.

[112]  F. Chen,et al.  Complete Genome Sequence of a Newcastle Disease Virus Strain Isolated from Broiler Breeder Flocks in China , 2012, Journal of Virology.

[113]  S. Krishnamurthy,et al.  High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus. , 2001, The Journal of general virology.

[114]  A. Lamb.  Paramyxoviridae : The virus and their replication , 1996 .

[115]  Xinglong Wang,et al.  Phylogenetic characterization and virulence of two Newcastle disease viruses isolated from wild birds in China. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[116]  B. Lambrecht,et al.  Immune Responses and Protection Against H5N1 Highly Pathogenic Avian Influenza Virus Induced by the Newcastle Disease Virus H5 Vaccine in Ducks , 2012, Avian diseases.

[117]  S. Elankumaran,et al.  Role of fusion protein cleavage site in the virulence of Newcastle disease virus , 2003, Microbial Pathogenesis.

[118]  A. L. Le Faou,et al.  High Genetic Diversity of Newcastle Disease Virus in Poultry in West and Central Africa: Cocirculation of Genotype XIV and Newly Defined Genotypes XVII and XVIII , 2013, Journal of Clinical Microbiology.

[119]  D. Garcin,et al.  Partial characterization of a Sendai virus replication promoter and the rule of six. , 1996, Virology.

[120]  A. García-Sastre,et al.  Protection against Respiratory Syncytial Virus by a Recombinant Newcastle Disease Virus Vector , 2006, Journal of Virology.

[121]  Yongqi Yan,et al.  Role of the Cytoplasmic Tail Amino Acid Sequences of Newcastle Disease Virus Hemagglutinin-Neuraminidase Protein in Virion Incorporation, Cell Fusion, and Pathogenicity , 2009, Journal of Virology.

[122]  B. Peeters,et al.  Rescue of Newcastle Disease Virus from Cloned cDNA: Evidence that Cleavability of the Fusion Protein Is a Major Determinant for Virulence , 1999, Journal of Virology.

[123]  E. Corey,et al.  Binding Temperature-Dependent Defect in Receptor Hemagglutinin-Neuraminidase Is due to a Disease Virus the Dimer Interface in the Newcastle Fusion Deficiency Induced by Mutations at , 2002 .

[124]  S. Elankumaran,et al.  A Recombinant Newcastle Disease Virus (NDV) Expressing VP2 Protein of Infectious Bursal Disease Virus (IBDV) Protects against NDV and IBDV , 2004, Journal of Virology.

[125]  P. Collins,et al.  Mutations in the Cytoplasmic Domain of the Newcastle Disease Virus Fusion Protein Confer Hyperfusogenic Phenotypes Modulating Viral Replication and Pathogenicity , 2013, Journal of Virology.

[126]  J. Sheehan,et al.  Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus , 1988, Journal of virology.

[127]  H. Granzow,et al.  Vaccination with Newcastle Disease Virus Vectored Vaccine Protects Chickens Against Highly Pathogenic H7 Avian Influenza Virus , 2009, Avian diseases.

[128]  P. Collins,et al.  Newcastle disease virus as a vaccine vector for humans. , 2008, Current opinion in molecular therapeutics.

[129]  D J Alexander,et al.  Newcastle disease and other avian paramyxoviruses. , 2000, Revue scientifique et technique.

[130]  Subrat N. Rout,et al.  Role of Untranslated Regions of the Hemagglutinin-Neuraminidase Gene in Replication and Pathogenicity of Newcastle Disease Virus , 2009, Journal of Virology.

[131]  A. García-Sastre,et al.  Newcastle Disease Virus V Protein Is a Determinant of Host Range Restriction , 2003, Journal of Virology.

[132]  S. Elankumaran,et al.  The Hemagglutinin-Neuraminidase Protein of Newcastle Disease Virus Determines Tropism and Virulence , 2004, Journal of Virology.

[133]  Yongqi Yan,et al.  A Y526Q Mutation in the Newcastle Disease Virus HN Protein Reduces Its Functional Activities and Attenuates Virus Replication and Pathogenicity , 2009, Journal of Virology.

[134]  S. B. Hitchner,et al.  A Laboratory Manual for the Isolation and Identification of Avian Pathogens , 1990 .

[135]  B. Murphy,et al.  Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens , 2007, Proceedings of the National Academy of Sciences.

[136]  S. Platt,et al.  Nucleic Acids Research Nucleotide sequence of the gene encoding the matrix protein of Newcastle disease virus , 2005 .

[137]  Subrat N. Rout,et al.  The Large Polymerase Protein Is Associated with the Virulence of Newcastle Disease Virus , 2008, Journal of Virology.

[138]  H. Su,et al.  Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs. , 2012, Virology.

[139]  Subrat N. Rout,et al.  Immunization of Chickens with Newcastle Disease Virus Expressing H5 Hemagglutinin Protects against Highly Pathogenic H5N1 Avian Influenza Viruses , 2009, PloS one.

[140]  P. V. Ravindra,et al.  HN protein of Newcastle disease virus causes apoptosis in chicken embryo fibroblast cells , 2008, Archives of Virology.